Novo Nordisk Rules Out Big M&A for Now as It Works to Steady Its Pipeline
“In every data room” but buying nothing large. A CEO a year into the job declining the move markets usually reward.
Egg-grown flu vaccines force a strain guess months ahead. mRNA compresses that lead time — which is the actual argument, not the 27%.
“In every data room” but buying nothing large. A CEO a year into the job declining the move markets usually reward.
It was not immune weakness that woke the sleeping viruses. It was inflammation — and one obscure virus family tracked with long COVID.
A trillion neurons, 46 million images, 15 months — and a $3 million milestone. The gap between those numbers is the honest measure of where AI discovery stands.
Ninety percent of trials fail. A platform claiming 90% accuracy at predicting outcomes is reporting its own figure — which is the part to hold onto.
COPD drugs open airways or damp inflammation broadly. A DPP1 inhibitor switches off the enzyme that arms the destructive enzymes in the first place.
One base inserted, one protein gone, no foreign DNA. Two beagles that people allergic to dogs did not react to — and a set of questions the field has not answered.
Five seconds from trigger to detonation, and almost no trace left behind. A defence mechanism nobody knew existed, in an animal that regenerates from fragments.
Comirnaty went from $38 billion to $4.4 billion in three years. Everything in this quarter’s results is a response to that single line.
A bean protein that traps virus particles, delivered by chewing. Ex vivo only — no person has yet chewed it in a trial.
One brain-age number hides where the aging is. Down to the voxel, the frontal and temporal lobes look older — and in Alzheimer’s, the hippocampus looks oldest.
A $121 billion company’s quarter beat estimates. The stock story is a $2.3 billion rival with a sweat chloride readout coming.